Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells

Nutrition and Cancer

Volumn 48, Issue 2, 2004, Pages 198-206

  Parnaud, Géraldine ^a   Li, PengFei ^a   Cassar, Georges ^b   Rouimi, Patrick ^a   Tulliez, Jacques ^a   Combaret, Lydie ^c   Gamet Payrastre, Laurence ^a  

^a CNRS   (France)

^b INSERM   (France)

^c CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLIN B1; PROTEASOME; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PROTEIN P21; RETINOBLASTOMA PROTEIN; ROSCOVITINE; SULFORAPHANE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL DEATH; CELL GROWTH; CELL STRAIN HT29; COLON CANCER; CULTURE MEDIUM; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; INTESTINE CELL; MITOSIS INHIBITION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VEGETABLE;

EID: 3843082891     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc4802_10     Document Type: Article

References (43)

1. Thornalley PJ: Isothiocyanates: mechanism of cancer chemopreventive action. Anticancer Drugs 13, 331-338, 2002.
2. Krul C, Humblot C, Philipp C, Vermeulen M, Van Nuenen M, et al.: Metabolism of sinigrin (2-propenyl glucosinolate) by the human colonic microflora in a dynamic in vitro large-intestinal model. Carcinogenesis 23, 1009-1016, 2002.
3. Chung FL, Conaway CC, Rao CV, and Reddy BS: Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethylisothiocyanate. Carcinogenesis 21, 2287-2291, 2000.
4. Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, et al.: Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci USA 99, 7610-7615, 2002.
5. Talalay P and Fahey JW: Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 131, 3027S-3033S, 2001.
6. Bonnesen C, Eggleston IM, and Hayes JD: Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res 61, 6120-6130, 2001.
7. Payen L, Sparfel L, Courtois A, Vernhet L, Guillouzo A, et al.: The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compounds. Cell Biol Toxicol 18, 221-233, 2002.
8. Heiss E, Herhaus C, Klimo K, Bartsch H, and Gerhauser C: Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J Biol Chem 276, 32008-32015, 2001.
9. Gamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, et al.: Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 60, 1426-1433, 2000.
10. Xu K and Thornalley PJ: Signal transduction activated by the cancer chemopreventive isothiocyanates: cleavage of BID protein, tyrosine phosphorylation and activation of JNK. Br J Cancer 84, 670-673, 2001.
11. Chiao JW, Chung FL, Kancherla R, Ahmed T, Mittelman A, et al.: Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int J Oncol 20, 631-636, 2002.
12. Fimognari C, Nusse M, Cesari R, Iori R, Cantelli-Forti G, et al.: Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis 23, 581-586, 2002.
13. Nakamura Y, Kawakami M, Yoshihiro A, Miyoshi N, Ohigashi H, et al.: Involvement of the mitochondrial death pathway in chemopreventive benzylisothiocyanate-induced apoptosis. J Biol Chem 277, 8492-8499, 2002.
14. Johnson DG and Walker CL: Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 39, 295-312, 1999.
15. Ando T, Kawabe T, Ohara H, Ducommun B, Itoh M, and Okamoto T: Involvement of the interaction between p21 and PCNA for the maintenance of G2/M arrest after DNA damage. J Biol Chem 276/46, 42971-42977, 2001.
16. Evan GI, Brown L, Whyte M, and Harrington E: Apoptosis and the cell cycle. Curr Opin Cell Biol 7, 825-834, 1995.
17. Choi KS, Eom YW, Kang Y, Ha MJ, Rhee H, Yoon JW, and Kim SJ: Cdc2 and Cdk2 kinase activated by transforming growth factor-beta1 trigger apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma cells. J Biol Chem 274, 31775-31783, 1999.
18. Vindelov L and Christensen IJ: An integrated set of methods for routine flow cytometric DNA analysis. Methods Cell Biol 33, 127-137, 1990.
19. Schaffner W and Weissmann C: A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal Biochem 56, 502-514, 1973.
20. Rao S, Porter DC, Chen X, Herliczek T, Lowe M, and Keyomarsi K: Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc Natl Acad Sci USA 96, 7797-7802, 1999.
21. Fimognari C, Nusse M, Berti F, Iori R, Cantelli-Forti G, et al.: Cyclin D3 and p53 mediate sulforaphane-induced cell cycle delay and apoptosis in non-transformed human T lymphocytes. Cell Mol Life Sci 59, 2004-2012, 2002.
22. Levi MS, Borne RF, and Williamson JS: A review of cancer chemopreventive agents. Curr Med Chem 8, 1349-1362, 2001.
23. Chadebech P, Truchet I, Brichese L, and Valette A: Up-regulation of cdc2 protein during paclitaxel-induced apoptosis. Int J Cancer 87, 779-786, 2000.
24. Meikrantz W and Schlegel R: Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J Biol Chem 271, 10205-10209, 1996.
25. Dulic V, Stein GH, Far DF, and Reed SI: Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol Cell Biol 18, 546-557, 1998.
26. Han Z, Wei W, Dunaway S, Darnowski JW, Calabresi P, et al.: Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J Biol Chem 277, 17154-17160, 2002.
27. Barboule N, Lafon C, Chadebech P, Vidal S, and Valette A: Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition. FEBS Lett 444, 32-37, 1999.
28. Archer SY, Meng S, Shei A, and Hodin RA: p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 95, 6791-6796, 1998.
29. Hsu SL, Yin SC, Liu MC, Reichert U, and Ho WL: Involvement of cyclin-dependent kinase activities in CD437-induced apoptosis. Exp Cell Res 252, 332-341, 1999.
30. Mahyar-Roemer M and Roemer K: p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 20, 3387-3398, 2001.
31. Chai F, Evdokiou A, Young GP, and Zalewski PD: Involvement of p21 (Waf1/Cip1) and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrate. Carcinogenesis 21, 7-14, 2000.
32. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, et al.: p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9(8), 935-944, 1995.
33. Hu PP, Shen X, Huang D, Liu Y, Counter C, and Wang XF: The MEK pathway is required for stimulation of p21 (WAF1/CIP1) by transforming growth factor-beta. J Biol Chem 274(50), 35381-35387, 1999.
34. Kim JA, Park KS, Kim HI, Oh SY, Ahn Y, et al.: Troglitazone activates p21Cip/WAF1 through the ERK pathway in HCT15 human colorectal cancer cells. Cancer Lett 179, 185-195, 2002.
35. Liu Y, Martindale JL, Gorospe M, and Holbrook NJ: Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res 56, 31-35, 1996.
36. Wang X, McGowan CH, Zhao M, He L, Downey JS, et al.: Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol 20, 4543-4552, 2000.
37. Dou QP and An B: Rb and apoptotic cell death. Front Biosci 3, d419-d430, 1998.
38. Guy M, Moorghen M, Bond JA, Collard TJ, Paraskeva C, et al.: Transcriptional down-regulation of the retinoblastoma protein is associated with differentiation and apoptosis in human colorectal epithelial cells. Br J Cancer 84, 520-528, 2001.
39. Sherr CJ: GI phase progression: cycling on cue. Cell 18(79), 551-555, 1994.
40. Vorlaufer E and Peters JM: Regulation of the cyclin B degradation system by an inhibitor of mitotic proteolysis. Mol Biol Cell 9, 1817-1831, 1998.
41. Farhana L, Dawson M, Rishi AK, Zhang Y, Van Buren E, et al.: Cyclin B and E2F-1 expression in prostate carcinoma cells treated with the novel retinoid CD437 are regulated by the ubiquitin-mediated pathway. Cancer Res 62, 3842-3849, 2002.
42. Pray TR, Parlati F, Huang J, Wong BR, Payan DG, et al.: Cell cycle regulatory E3 ubiquitin ligases as anticancer targets. Drug Resist Updat 5, 249-258, 2002.
43. Lin H, Liu XY, Subramanian B, Nakeff A, Valeriote F, et al.: Mitotic arrest induced by XK469, a novel antitumor agent, is correlated with the inhibition of cyclin B1 ubiquitination. Int J Cancer 97, 121-128, 2002.